Schedule 13D ownership disclosure
Fate Therapeutics Inc
Security class unavailable · CUSIP: 31189P102
Event date: 2018-07-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 12.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-18-041503
- Form type
- SC 13D
- Filer
- FATE THERAPEUTICS INC
- CIK
- CIK 1434316
- Filed
- Aug 02, 2018
- Reporting period
- Jul 31, 2018
- Description
- Schedule 13D beneficial ownership